Vanguard Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Sell |
|
|||||
|
2025
Q1 | $326K | Sell |
|
|||||
|
2024
Q4 | $653K | Hold |
|
|||||
|
2024
Q3 | $4.07M | Hold |
|
|||||
|
2024
Q2 | $3.77M | Hold |
|
|||||
|
2024
Q1 | $5.84M | Sell |
|
|||||
|
2023
Q4 | $5.43M | Buy |
|
|||||
|
2023
Q3 | $3.93M | Hold |
|
|||||
|
2023
Q2 | $3.22M | Sell |
|
|||||
|
2023
Q1 | $3.4M | Sell |
|
|||||
|
2022
Q4 | $5.29M | Buy |
|
|||||
|
2022
Q3 | $53.5M | Buy |
|
|||||
|
2022
Q2 | $27M | Buy |
|
|||||
|
2022
Q1 | $35.7M | Buy |
|
|||||
|
2021
Q4 | $27.6M | Buy |
|
|||||
|
2021
Q3 | $24M | Buy |
|
|||||
|
2021
Q2 | $24.7M | Buy |
|
|||||
|
2021
Q1 | $24.4M | Buy |
|
|||||
|
2020
Q4 | $21.3M | Sell |
|
|||||
|
2020
Q3 | $25.3M | Sell |
|
|||||
|
2020
Q2 | $31M | Buy |
|
|||||
|
2020
Q1 | $19.8M | Buy |
|
|||||
|
2019
Q4 | $22.2M | Buy |
|